Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge

Cited by (351)

Items 201–300 of 351

  1. Nanotechnology for organ-tunable gene editing
    Roy van der Meel · 2020 · Nature Nanotechnology
  2. In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection
    Abdullah Ely, Prashika Singh, Tiffany S. Smith, Patrick B. Arbuthnot · 2020 · Advanced Drug Delivery Reviews
  3. Designing biomaterials for the delivery of RNA therapeutics to stimulate bone healing
    Lea Andrée, Fang Yang, Roland E. Brock, Sander C.G. Leeuwenburgh · 2021 · Materials Today Bio
  4. Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors
    Ester Blanco, Luisa Chocarro, Leticia Fernández, Ana Bocanegra, Hugo Arasanz, Miriam Echaide, Maider Garnica, Sergio Piñeiro‐Hermida, Grazyna T. Kochan, David Escors · 2023 · International Journal of Molecular Sciences
  5. Immunotherapy perspectives in the new era of B-cell editing
    Natsuko Ueda, Marine Cahen, Yannic Danger, Jérôme Moreaux, Christophe Sirac, Michel Cogné · 2021 · Blood Advances
  6. The road to effective and accessible antibody therapies against Ebola virus
    Hugues Fausther‐Bovendo, Gary Kobinger · 2022 · Current Opinion in Virology
  7. Customizable Lipid Nanoparticle Materials for the Delivery of siRNAs and mRNAs
    Owen S. Fenton, Kevin J. Kauffman, Rebecca L. McClellan, James C. Kaczmarek, Manhao D. Zeng, Jason L. Andresen, Luke H. Rhym, Michael W. Heartlein, Frank DeRosa, Daniel G. Anderson · 2018 · Angewandte Chemie
  8. Nano-Encapsulation and Conjugation Applied in the Development of Lipid Nanoparticles Delivering Nucleic Acid Materials to Enable Gene Therapies
    Linh Đinh, Lanesa Mahon, Bingfang Yan · 2024 · Applied Nano
  9. In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infection
    Christine Tkaczyk, Michael R. Newton, Mun Mun Patnaik, George Thom, Martin Strain, Adam Gamson, Olalekan Daramola, Andal Murthy, Julie A. Douthwaite, Oleg Stepanov et al. · 2024 · Molecular Therapy
  10. Lipid nanoparticle-encapsulated mRNA therapy corrects serum total bilirubin level in Crigler-Najjar syndrome mouse model
    Jenny A. Greig, Joanna K Chorazeczewski, Vivek Chowdhary, Melanie K. Smith, Matthew Jennis, James C. Tarrant, Elizabeth L. Buza, Kimberly A. Coughlan, Paolo G.V. Martini, James M. Wilson · 2023 · Molecular Therapy — Methods & Clinical Development
  11. Designing novel multiepitope mRNA vaccine targeting Hendra virus (HeV): An integrative approach utilizing immunoinformatics, reverse vaccinology, and molecular dynamics simulation
    Ahmad Abdullah Mahdeen, Imam Hossain, Md. Habib Ullah Masum, Md. Sajedul Islam, T M Fazla Rabbi · 2024 · PLoS ONE
  12. HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins
    Alexander Falkenhagen, Sadhna Joshi · 2018 · Molecular Therapy — Nucleic Acids
  13. Bridging the Clinical Gap for DNA-Based Antibody Therapy Through Translational Studies in Sheep
    Kevin Hollevoet, Stéphanie De Vleeschauwer, Elien De Smidt · 2019 · Human Gene Therapy
  14. In Vitro Investigations on Optimizing and Nebulization of IVT-mRNA Formulations for Potential Pulmonary-Based Alpha-1-Antitrypsin Deficiency Treatment
    Joseph Rosenecker, Shan Guan, Max Darmstädter, Chuanfei Xu · 2021 · Pharmaceutics
  15. Hepatocyte Nuclear Factor 4 alpha 2 Messenger RNA Reprograms Liver‐Enriched Transcription Factors and Functional Proteins in End‐Stage Cirrhotic Human Hepatocytes
    Edgar N. Tafaleng, Amitava Mukherjee, Aaron W. Bell, Kazutoyo Morita, Jorge Guzman‐Lepe, Nils Haep, Rodrigo Machado Florentino, Ricardo Díaz‐Aragon, Carla Frau, Alina Ostrowska et al. · 2021 · Hepatology Communications
  16. Self-assembled amphiphilic copolymers as dual delivery system for immunotherapy
    Thomas Trimaille, Céline Lacroix, Bernard Verrier · 2019 · European Journal of Pharmaceutics and Biopharmaceutics
  17. Synthetic mRNA rescues very long-chain acyl-CoA dehydrogenase deficiency in patient fibroblasts and a murine model
    Xuejun Zhao, Al-Walid A. Mohsen, Stephanie J. Mihalik, Keaton J. Solo, Ermal Aliu, Huifang Shi, Shakuntala Basu, Catherine Kochersperger, Clinton Van’t Land, Anuradha Karunanidhi et al. · 2022 · Molecular Genetics and Metabolism
  18. Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines
    Xiao Guo, Dongying Liu, Yukai Huang, Youcai Deng, Ying Wang, Jingrui Mao, Yuancheng Zhou, Yongai Xiong, Xinghong Gao · 2023 · Virology Journal
  19. Regulatory circular RNAs in viral diseases: applications in diagnosis and therapy
    Wei J. Wang, Lei Sun, Meng-Ting Huang, Yun Quan, Tao Jiang, Zhichao Miao, Qiong Zhang · 2023 · RNA Biology
  20. mRNA and Synthesis-Based Therapeutic Proteins: A Non-Recombinant Affordable Option
    Sarfaraz K. Niazi, Matthias Magoola · 2023 · Biologics
  21. Monoclonal Antibodies: A Prospective and Retrospective View
    Sivaccumar, Jwala, Sandomenico, Annamaria, Vitagliano, Luigi, Ruvo, Menotti · 2021 · Current Medicinal Chemistry
  22. Self-assembled small messenger RNA nanospheres for efficient therapeutic apoptin expression and synergistic Gene-Chemotherapy of breast cancer
    Yuxia Tang, Xiang Liao, Chunyan Wang · 2021 · Journal of Colloid and Interface Science
  23. SEMPER: Stoichiometric expression of mRNA polycistrons by eukaryotic ribosomes for compact, ratio-tunable multi-gene expression
    Mengtong Duan, Ishaan Dev, Andrew Y. Lu, Goar Ayrapetyan, Mei Yi You, Mikhail G. Shapiro · 2024 · Cell Systems
  24. mRNA vaccines against HIV : Hopes and challenges
    Akmal Zubair, Hanbal Ahmad, Muhammad Muaz Arif, Muhammad Ali · 2025 · HIV Medicine
  25. The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing
    Parichehr Hassanzadeh · 2021 · Life Sciences
  26. Innovation in active and passive immunisation of people who are immunocompromised: a call to action
    Joshua Aiden Hill, Jim B. Boonyaratanakornkit, Malgorzata Mikulska, Benjamin W. Teh, William O. Hahn, Ghady Haidar, Catherine Liu, Deepali Kumar, Michael G. Ison, Natasha Halasa · 2025 · The Lancet Infectious Diseases
  27. Regulation of Antiviral Immune Response by N6-Methyladenosine of mRNA
    Baoxin Zhao, Weijie Wang, Yan Zhao, Hongxiu Qiao, Zhiyun Gao, Xia Chuai · 2021 · Frontiers in Microbiology
  28. Messenger RNA rescues medium-chain acyl-CoA dehydrogenase deficiency in fibroblasts from patients and a murine model
    Xuejun Zhao, Al-Walid A. Mohsen, Stephanie J. Mihalik, Keaton J. Solo, Shakuntala Basu, Ermal Aliu, Huifang Shi, Catherine Kochersberger, Anuradha Karunanidhi, Clinton Van’t Land et al. · 2023 · Human Molecular Genetics
  29. In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies
    Chasity D. Andrews, Yaoxing Huang, David D. Ho, Rachel A. Liberatore · 2020 · Emerging Microbes & Infections
  30. Advances in mRNA‐Lipid Nanoparticle Engineering for Immune Cell Targeting and Immune Modulation
    Cheesue Kim, Yeji Lee, Hyukjin Lee, Byung‐Soo Kim · 2025 · Small Methods
  31. Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies
    Zehua Sun, Lixin Yan, Jiansong Tang, Qian Qian, Jerica L. Lenberg, Dandan Zhu, Wan Liu, Kao Wu, Yilin Wang, Shiqiang Lu · 2017 · Virus Research
  32. Metabolically stabilized double-stranded mRNA polyplexes
    Jacob A. Poliskey, Samuel Thomas Crowley, Raghu Ramanathan, Christopher W. White, Basil Mathew, Kevin G. Rice · 2018 · Gene Therapy
  33. Applications and challenges of biomaterial mediated mRNA delivery
    Huapan Fang, Qian Chen · 2022 · Exploration of Targeted Anti-tumor Therapy
  34. Exploitation of Synthetic mRNA To Drive Immune Effector Cell Recruitment and Functional Reprogramming In Vivo
    Yitian Xu, Lu Huang, Jonathan L. Kirschman, Daryll A. Vanover, Pooja Munnilal Tiwari, Philip J. Santangelo, Xiling Shen, David G. Russell · 2018 · The Journal of Immunology
  35. Empowering gene delivery with protein engineering platforms
    Monika Kizerwetter, Kevin Pietz, Luke M. Tomasovic, Jamie B. Spangler · 2022 · Gene Therapy
  36. Active immunoprophylaxis with a synthetic DNA-encoded monoclonal anti-respiratory syncytial virus scFv-Fc fusion protein confers protection against infection and durable activity
    Katherine Schultheis, Holly M. Pugh, Janet Oh, Jacklyn Nguyen, Bryan S. Yung, Charles Reed, Neil S. Cooch, Jing Chen, Jian Yan, Kar Muthumani et al. · 2020 · Human Vaccines & Immunotherapeutics
  37. An integrated self-powered 3D printed sample concentrator for highly sensitive molecular detection of HIV in whole blood at the point of care
    Karteek Kadimisetty, Kun Yin, Aoife M. Roche · 2021 · The Analyst
  38. Transformative Materials for Interfacial Drug Delivery
    Prachi Bharat Desai, Anshuman Dasgupta, Alexandros Marios Sofias, Quim Peña, Robert Göstl, Ioana Slabu, Ulrich Schwaneberg, Thomas Stiehl, Wolfgang Wagner, Stefan Jockenhoevel et al. · 2023 · Advanced Healthcare Materials
  39. Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model
    Kevin Hollevoet, Debby Thomas, Griet Compernolle et al. · 2022 · Frontiers in Oncology
  40. Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster
    Yanan Zhang, Hong-Qing Zhang, Guifeng Wang, Zherui Zhang, Jiaqi Li, Xiaoling Chen, Yan-Yan Hu, Xiang‐Yue Zeng, Yu-Jia Shi, Jing Wang et al. · 2022 · Antiviral Research
  41. Delivery platforms for broadly neutralizing antibodies
    Lok Raj Joshi, Nicolás M. S. Gálvez, Sukanya Ghosh, David B. Weiner, Alejandro Benjamin Balazs · 2023 · Current Opinion in HIV and AIDS
  42. Pharmacokinetic Analyses of a Lipid Nanoparticle-Encapsulated mRNA-Encoded Antibody against Rift Valley Fever Virus
    Shuo Wang, Ziling Zhu, Jianmin Li · 2024 · Molecular Pharmaceutics
  43. mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses
    Janan Shoja Doost, Fatemeh Fazel, Nitish Boodhoo, Shayan Sharif · 2024 · Viruses
  44. Towards mRNA therapeutics 2.0
    Kenneth R. Chien, Kylie S. Foo, Nevin Witman · 2026 · Nature Reviews Drug Discovery
  45. Coronavirus vaccines get a biotech boost
    Amber Dance · 2020 · Nature
  46. In vivo production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infection
    Yuta Suzuki, Takayuki Miyazaki, Yoko Ida, Tatsuya Suzuki, Yumi Itoh, Shuto Nakao, Keita Kondo, Kenji Kubara, Keisuke Nishioka, Hiroki Muto et al. · 2025 · Molecular Therapy — Nucleic Acids
  47. Humanised mouse models for haematopoiesis and infectious diseases
    Veronika Lysenko, Donal McHugh, Lena Behrmann, Mary-Aude Rochat, Christian Matthias Wilk, Larisa V. Kovtonyuk, Jean‐Pierre Bourquin, Christian Münz, Markus Gabriel Manz, Roberto F. Speck et al. · 2017 · Swiss Medical Weekly
  48. DNA-based delivery of anti-DR5 Nanobodies improves exposure and anti-tumor efficacy over protein-based administration
    Giles Vermeire, Elien De Smidt, Peter Casteels, Nick Geukens, Paul J. Declerck, Kevin Hollevoet · 2020 · Cancer Gene Therapy
  49. RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
    Mohammad Natami, Amirsasan Gorgzadeh, Arsalan Gholipour, Seyedeh Narges Fatemi, Nima Firouzeh, Maryam Zokaei, Saad Hasan Mohammed Ali, Hadis Kheradjoo, Somayeh Sedighi, Omid Gholizadeh et al. · 2024 · Journal of Nanobiotechnology · Retracted
  50. Progress in novel delivery technologies to improve efficacy of therapeutic antibodies
    Wenli Sun, Yanling Wu, Tianlei Ying · 2024 · Antiviral Research
  51. Silica nanoparticles as advanced platforms for nucleic acid delivery
    Mónica L. Fanárraga, Lorena García‐Hevia · 2026 · Materials Today Bio
  52. Non‐Viral Nucleic Acid Delivery System for RNA Therapeutics
    Lianxiao Liu, Yiming Zhou, Anqiu Xu, Chenglong Wang, Ning Li, Hongwei Huang, Yuntao Zhang, Xiaoming Yang · 2023 · Advanced Therapeutics
  53. RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens
    Naga Suresh Kola, Dhruv Patel, Aneesh Thakur · 2024 · Methods in molecular biology
  54. Single-hit genome editing optimized for maturation in B cells redirects their specificity toward tumor antigens
    Natsuko Ueda, Marine Cahen, Jenny Léonard · 2024 · Scientific Reports
  55. A Review of CCR5 Antibodies Against HIV: Current and Future Aspects
    Pavan Kumar Prathipati, Subhra Mandal, Christopher J. Destache · 2019 · Therapeutic Delivery
  56. Path to Success and Future Impact of Nucleic Acid Vaccines: DNA and mRNA
    Jeffrey B. Ulmer, Margaret A. Liu · 2021 · Molecular Frontiers Journal
  57. Targeting IgE and Th2-Cytokines in Allergy: Brief Updates on Monoclonal Antibodies and Antibody Gene Therapy
    Henry C. Ezechukwu, Oyelola Abdulwasiu Adegboye, Wahab Oluwanisola Okunowo, Theophilus I. Emeto · 2023 · Allergies
  58. Clinical Analysis and Applications of mRNA Vaccines in Infectious Diseases and Cancer Treatment
    Paa Kwesi Ankrah, Ajibola Olaoluwa Ilesanmi, Amos Olalekan Akinyemi, Victor Lasehinde, Oluwapelumi Eniola Adurosakin, Oluwatobi H Ajayi · 2023 · Cureus
  59. Controlling Protein Expression by Delivery of RNA Therapeutics Using Lipid Nanoparticles
    Paulo J.C. Lin, Ying K. Tam · 2019 · Elsevier eBooks
  60. PCR-generated DNA templates enable efficient, rapid, and cost-effective mRNA synthesis
    Naveen Kumar, Nicholas C. Hazell, Jiani Bei, Tina K. Nguyen, Haitao Hu · 2025 · Methods
  61. Optimizing the targeting of lipid nanoparticles for gene therapy
    Lei Yue, Xiulei Gao, Wei Qi, Luhong Zhang, Yuefei Wang · 2025 · Nanoscale Horizons
  62. mRNA technology for the prevention and treatment of HIV-1 infection
    Chuang LIU, Alexey V. Yaremenko, Xiaolong Li, Xinru You, Xiaoyu Zhu, Nuo Liu, Wei Chen, Na Kong, Tian Xie, Gaurav D. Gaiha et al. · 2026 · Nature Reviews Bioengineering
  63. Viral protease-initiated lytic cell death as a universal antiviral mRNA therapy
    Li Li, Xiuli Yan, H Wang, Hangyu Zhou, Yu-Yan Li, Wenlong Ma, Li J, Rong-Rong Zhang, Lu Lv, Xing‐Yao Huang et al. · 2026 · Cell
  64. A pan-orthoebolavirus neutralizing antibody encoded by mRNA effectively prevents virus infection
    Pengfei Fan, Bingjie Sun, Zixuan Liu, Ting Fang, Yi Ren, Xiaofan Zhao, Zhenwei Song, Yilong Yang, Jianmin Li, Changming Yu et al. · 2024 · Emerging Microbes & Infections
  65. A review of advances in in vitro RNA preparation by ssRNAP
    Yuan Shen, Dong-Qi Yang, Yuan Liu, Jia-En Lao, Chunqing Liu, Xiaoya Gao, Yun-Ru He, Heng Xia · 2025 · International Journal of Biological Macromolecules
  66. Direct and Selective Modification of RNA – An Open Challenge in Nucleic Acid Chemistry
    Dennis G. Gillingham, Dnyaneshwar B. Rasale · 2018 · CHIMIA International Journal for Chemistry
  67. Advances in mRNA vaccines for viral diseases
    Yukai Huang, Xuerui Zhu, Xiao Guo, Yuancheng Zhou, Dongying Liu, Jingrui Mao, Yongai Xiong, Youcai Deng, Xinghong Gao · 2023 · Journal of Medical Virology
  68. Stoichiometric expression of messenger polycistrons by eukaryotic ribosomes (SEMPER) for compact, ratio-tunable multi-gene expression from single mRNAs
    Meng-Tong Duan, Ishaan Dev, A. Lu, Mei-Yi You, M. Shapiro · 2023 · bioRxiv
  69. Safeguarding VSMC Contractile Phenotype With In Situ circRNA‐mediated Endothelial Olaratumab Engineering to Prevent Vascular Graft Stenosis
    Shunqi Hu, Shifeng Ling, Fubang Liang et al. · 2026 · Advanced Materials
  70. Does the SARS-CoV-2 mRNA vaccine and its serum IgG levels affect fertility treatments and obstetric outcomes? An observational cohort study
    Netanella Danielli Miller, Nitzan Goren Gepstein, Dovev Cohen, Einat Haikin Herzberger, Hila Shalev Ram, Jordana Mashiach Friedler, Maya Sharon‐Weiner, Roni Rahav, Victoria Indenbaum, Yaniv Lustig et al. · 2024 · Clinical and Experimental Medicine
  71. Structure and sequence engineering approaches to improve in vivo expression of nucleic acid-delivered antibodies
    Michaela Helble, Jacqueline D. Chu, Kaitlyn Flowers, Abigail Rose Trachtman, Alana Huynh, Amber Kim, Nicholas Shupin, Casey E. Hojecki, Ebony Nicole Gary, Shahlo O. Solieva et al. · 2024 · Molecular Therapy
  72. Modified h CFTR mRNA restores normal lung function in a mouse model of cystic fibrosis
    AKM Ashiqul Haque, Alexander Dewerth, Justin S. Antony, Joachim Riethmüller, Ngadhnjim Latifi, Hanzey Yasar, Petra Weinmann, Nicoletta Pedemonte, Elvira Sondo, Julie Laval et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Incorporating mRNA therapeutics into biological treatments of hematologic malignancies
    Jaromir Hunia, Jaromir Tomasik, Natalia Czerwik, Parmida Sadat Pezeshki, Dominika Nowis · 2025 · Frontiers in Immunology
  74. A tumor-selective mRNA system enables precision cancer treatment
    Magdalena M. Żak, Jimeen Yoo, Alberto Utrero‐Rico, Wencke Walter, Gayatri Mainkar, Matthew Adjmi, Ann Anu Kurian, Ashikur Rahaman, Daniel Lozano‐Ojalvo, Jordi Ochando et al. · 2025 · Molecular Therapy
  75. Development of mRNA Cancer Vaccines: Delivery Strategies and Immunogenicity Optimization
    Awais Ali · 2025 · Current Medical Science
  76. Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications
    Saumya Nishanga Heendeniya, Suxiang Chen, S. H. Bhatti, Qurat ul ain Zahra, Kamal Rahimizadeh, Bal Hari Poudel, Steve Donald Wilton, Rakesh Naduvile Veedu · 2025 · Experimental Biology and Medicine
  77. Fc-free single-chain antibody mRNA therapy for airway infection of multidrug-resistant Pseudomonas aeruginosa
    Mao Kinoshita, Ken Kawaguchi, Yuki Mochida, Nguyen Bui Thao Le, Atsushi Kainuma, Naoko Takeda-Miyata, Motohiro Kojima, Teiji Sawa, Satoshi Uchida · 2026 · Nature Communications
  78. RNA Vaccines: The Evolution, Applications, and the Challenges Ahead
    Ishani Banerji, Shreya Bhattacharjee, Kamalika Mukherjee, Suvendra N. Bhattacharyya · 2023 · Springer eBooks
  79. Recent applications of RNA therapeutic in clinics
    Huyen Trang Ha Thi, Van Thai Than · 2024 · Progress in molecular biology and translational science
  80. The 14th International Podocyte Conference 2023: from podocyte biology to glomerular medicine
    Sybille Koehler, Felicitas E. Hengel, Bernhard Dumoulin, Laurel J. Damashek, Lawrence B. Holzman, Katalin Suszták, Tobias Bruno Huber · 2024 · Kidney International
  81. vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target
    Alejandro Manzanares-Guzmán, Pavel H. Lugo-Fabres, Tanya Amanda Camacho-Villegas · 2024 · Antibodies
  82. mRNA encoding antibodies against hemagglutinin and nucleoprotein prevents influenza virus infection in vitro
    Yana A. Zabrodskaya, Nina V. Gavrilova, Ekaterina A. Elpaeva, Alexey A. Lozhkov, Vera V. Vysochinskaya, Olga A. Dobrovolskaya, Olesya V. Dovbysh, E.L. Zimmerman, P N Dav, Aleksandra V. Brodskaia et al. · 2024 · Biochemical and Biophysical Research Communications
  83. Nebulization of an mRNA-encoded monoclonal antibody for passive immunization of foals against Rhodococcus equi
    Rebecca M. Legere, Jeannine A. Ott, Cristina Poveda, Daryll A. Vanover, Karin E. R. Borba, Jae Yeon Joo, Cameron Lee Martin, Bibiana Petri da Silveira, Jocelyne M. Bray, Kerstin K. Landrock et al. · 2025 · Molecular Therapy
  84. The genetic shortcut to antibody drugs
    Amanda B. Keener · 2018 · Nature
  85. Evaluation of mRNA Transfection Reagents for mRNA Delivery and Vaccine Efficacy via Intramuscular Injection in Mice
    Jungho Kim, Jihyun Yang, Suhyeon Heo, Ha Ryoung Poo · 2025 · ACS Applied Bio Materials
  86. Using modified mRNA for cardiomyocyte proliferation and cardiac genetic disease modelling and treatment
    Christopher A. P. Batho, James E. Hudson, Catherine H. Wilson · 2025 · Biochemical Society Transactions
  87. mRNA-Encoded antibodies as a next-generation therapeutic paradigm: a rapid and adaptive platform for the prevention and treatment of emerging and re-emerging infectious diseases — A critical review
    Dilpreet Singh · 2026 · Immunologic Research
  88. Harnessing mRNA for the expression of monoclonal IgG and IgA in non-human primates
    Romy Rouzeau, Hayden R. Schmidt, Cailin E. Deal, Joel D. Allen, Dawn M. Dudley, Iszac Burton, Eva G. Rakasz, Obadiah J. Plante, Max Crispin, Andrea Carfı́ et al. · 2026 · Frontiers in Immunology
  89. Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression
    Linda Zeng, Jingxian Shu, Shuping Zhong, Xin Dong, Yongjian Wu, Xi Huang · 2026 · Molecular Therapy
  90. Lyophilized monoclonal antibody (mAb) encoded mRNA—lipid nanoparticles (LNPs) lead to stable in vivo expression of mAb after room temperature storage
    Zimeng Wang, Bei Cheng, Christine Tkaczyk, Michael Newton, Shuolin Cui, Bohdan Andreiuk, Sanjib Saha, Sabrina Khan, Charles H. Chen, Bin Yang et al. · 2026 · AAPS Open
  91. RNA Therapeutics in Viral Infections and Cancer: Mechanisms, Challenges, and Prospects: A Review
    Evgenii Aleksandrovich Generalov, Alexei B. Shevelev, Dmitry Romanov, Olga A. Tarasova, Natalia V. Pozdniakova · 2026 · Pharmaceutics
  92. The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice
    Zhiyin An, Yu Zhang, Xiang Yu, Jia Hui XIA, Yanan Yin, Guoming Li, Jing Lu, Xuemei Fan, Yingjie Xu · 2023 · Pharmaceutics
  93. Induction of long-term tolerance to a specific antigen using anti-CD3 lipid nanoparticles following gene therapy
    Chun‐Yu Chen, Amber Vander Kooi, Alex Cavedon, Xiaohe Cai, Jonathan Hoggatt, Paolo G.V. Martini, Carol H. Miao · 2023 · Molecular Therapy — Nucleic Acids
  94. Development and optimization of an mRNA-vectored single-chain IgA1 isotype monoclonal antibody with potential to treat or prevent dengue virus infection
    Thanh Nguyen, Chad Gebo, Joseph Q. Lu · 2025 · Antiviral Research
  95. mRNA-based vaccines and therapies - a revolutionary approach for conquering fast-spreading infections and other clinical applications: a review
    Mingyue Pan, Weiling Cao, Jingbo Zhai, Chunfu Zheng, Yingying Xu, Peng Zhang · 2025 · International Journal of Biological Macromolecules
  96. In The Matter Of The Virus That Causes Corona Virus Disease (COVID-19), SARS-COV-2: A Case Predicted By The Theory Of Chaos
    H.Y. Lim Tung · 2020
  97. Design and optimization of mRNAs encoding an Anti-TIGIT antibody with therapeutic potential for cancer in TIGIT-humanized BALB/c Mice
    Jingmin Cui, Gulisaina Qiaerxie, Hui Qin, Feng Long, Xi Wang, Yang Zhixin, Peng Du, Yong Cui · 2023 · Archives of Pharmacy and Pharmaceutical Sciences
  98. The mRNA vaccine contributors: Assessing their impact through a mainstream lens
    Mei Hsiu‐Ching Ho, John S. Liu, Weiping Wang, Thomas Chiang Chuang · 2025 · Technological Forecasting and Social Change
  99. Intravaginal delivery of mRNA-encoded antibodies with enhanced breadth and potency for SHIV/HIV protection
    Jae Yeon Joo, Peng Xiao, Susan P. John, Daryll A. Vanover, Hannah E. Peck, Loren E. Sasser, Deepanwita Bose, Younghun Jung, Jaehyeon Hwang, Chiara Zurla et al. · 2025 · Nature Communications
  100. mRNA-delivered neutralizing antibodies confer protection against SARS-CoV-2 in animal models
    Nicholas C. Hazell, Rachel A. Reyna, Awadalkareem Adam, Srinivasa Reddy Bonam, Jiani Bei, Naveen Kumar, Tina Nguyen, Jessica A. Plante, Tong Wu, David Hughes Walker et al. · 2026 · Journal of Virology